BCTX (Briacell Therapeutics Corp. Common Shares) Stock Analysis

Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BCTX trades at $3.96 with a market cap of $24.29M and a P/E ratio of -0.06. BCTX moved +9.69% today. Year to date, BCTX is -49.28%; over the trailing twelve months it is -89.10%. Its 52-week range spans $2.98 to $214.50. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest BCTX stock research?

Briacell Therapeutics Corp. Common Shares (BCTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BCTX moved +9.69% today.

BCTX Key Metrics

Key financial metrics for BCTX
MetricValue
Price$3.96
Market Cap$24.29M
P/E Ratio-0.06
EPS$-62.19
Dividend Yield0.00%
52-Week High$214.50
52-Week Low$2.98
Volume944
Avg Volume0
Revenue (TTM)$0
Net Income$-26.56M
Gross Margin0.00%

Latest BCTX News

Recent BCTX Insider Trades

  • Lustig Marc bought 902.93K (~$2.00M) on May 14, 2024.
  • Bondarenko Jamieson bought 28.00K (~$128.24K) on Dec 28, 2022.
  • Bondarenko Jamieson bought 22.00K (~$117.70K) on Dec 20, 2022.

BCTX Analyst Consensus

BCTX analyst coverage data. Average price target: $0.00.

Common questions about BCTX

What can I research for BCTX on Rallies?
Briacell Therapeutics Corp. Common Shares (BCTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BCTX moved +9.69% today.
Does Rallies show live market data for BCTX?
Rallies combines live market context with ticker research for BCTX, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
BCTX

BCTX